Suppression of PBK/TOPK not only impaired the proliferation of hepatocellular carcinoma cells but also resulted in an inhibitory effect of fibroblast growth factor (FGF21) treatment on D-galactose (D-gal)-induced hepatocyte apoptosis [34,35]. This evidence concerns the gene PBK and hepatocellular carcinoma.